Grifols SA (GRFS) has a profit margin of 5.58%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for GRFS is 5.58% as of March 2026. That compares with 2.34% in the prior-year period — up 138.5% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Grifols SA's historical trend and sector peers before judging valuation or financial health.
Over the past year, GRFS's profit margin moved from 2.34% to 5.58% — a 138.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Grifols SA's valuation or profitability profile.
Against Healthcare companies, GRFS currently prints 5.58% for profit margin, while the sector average sits near 15.58%. That is roughly 64.2% below the sector mean. Large gaps often invite a closer look at Grifols SA's growth, margins, and balance sheet.
Profit Margin shows how effectively Grifols SA converts resources into returns. At 5.58%, GRFS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 2.34% in the prior-year period — up 138.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GRFS's profit margin (5.58%), review year-over-year change from 2.34%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.